AOD‑9604 and Metabolic Peptide Research

AOD-9604 cardiovascular research must carefully distinguish direct cardiovascular effects from indirect effects mediated by adipose mass reduction and secondary lipid/inflammatory profile improvement. The design approach requires: 1) pair-feeding controls to isolate the metabolic effect of AOD-9604 from caloric restriction driven by reduced appetite (AOD-9604 is reported not to affect food intake, but pair-fed controls eliminate confounding entirely); 2) body-weight-matched controls (comparing AOD-9604-treated obese to calorie-restriction-matched obese animals normalised to the same body weight) to isolate direct effects from adiposity reduction; and 3) direct in vitro experiments in cardiomyocytes, endothelial cells, and vascular smooth muscle to test receptor-level cardiovascular actions independent of systemic metabolic context. Appropriate positive controls include: recombinant GH (to test whether full GH receptor-mediated cardiovascular effects exceed AOD-9604 fragment effects), β3-AR agonist CL-316,243 (to test the β3-AR pathway contribution to any observed cardiovascular effects), and orlistat or pair-feeding (as fat-mass-reducing comparators without AOD-9604 pharmacology) to allow attribution of cardiovascular benefit to the specific pharmacological actions of AOD-9604 beyond simple fat loss. 🔗 Related Reading: For complementary GH-axis adipose and metabolic biology, see our post on CJC-1295 and Adipose Biology Research.

Key considerations and protocol notes for each peptide in this cheat sheet. Survodutide is an experimental weekly injection being studied for weight loss. It works by curbing appetite and boosting the number of calories your body burns, and early studies show it also helps with a liver condition called MASH. Performance L-Carnitine is a natural compound that helps your cells burn fat for energy and can support recovery after exercise. Injectable forms are popular because the body absorbs them better than carnitine taken by mouth. BAM-15 is an experimental compound that helps the body burn fat without raising body temperature, which makes it safer than similar older compounds. Most of what we know comes from animal studies, not humans. Mazdutide is an experimental injection being studied for weight loss and blood sugar control in type 2 diabetes. It works by curbing appetite and helping your body burn more energy. Cagrilintide mimics a natural hormone called amylin to help curb your appetite. MOTS-c is a peptide that helps regulate metabolism and mimics some of the benefits of exercise. SS-31 supports the mitochondria, the energy-producing parts of your cells. This is Tirzepatide, a medication that activates two gut hormone pathways (GIP and GLP-1) to help with weight loss and blood sugar. Some people use very small 'microdoses' to get benefits with fewer side effects, taken weekly or every other day. NAD+ is a molecule your cells need to produce energy. This 500 mg vial is a good starting size for a standard, ongoing NAD+ routine. This is Semaglutide, a long-acting medication that helps control appetite and blood sugar. It's also available as a ready-to-use pen that doesn't require mixing with water. This is Retatrutide, an experimental medication that activates three different gut hormone pathways at once. Taking very small 'microdoses' can provide benefits with fewer side effects. 5-Amino-1MQ supports mitochondrial function and can help with fat loss. AOD-9604 is a small fragment of growth hormone that helps promote fat burning. It needs to be mixed with a special combination of water and a mild acid to fully dissolve. SLU-PP-332 is a lab-made compound (not technically a peptide) that helps boost mitochondrial function and endurance, and is used for fat loss. All the dosing data we have comes from mouse studies — there's no human safety data yet.